首页> 外文期刊>Journal of Carbohydrate Chemistry >SYNTHESIS OF SIALYL-alpha-(2->3)-NEOLACTOTETRAOSE DERIVATIVES MODIFIED AT C-2 OF THE N-ACETYLGLUCOSAMINE RESIDUE: PROBES FOR INVESTIGATION OF ACCEPTOR SPECIFICITY OF HUMAN alpha-1,3-FUCOSYLTRANSFERASES, FUC-TVII AND FUC-TVI
【24h】

SYNTHESIS OF SIALYL-alpha-(2->3)-NEOLACTOTETRAOSE DERIVATIVES MODIFIED AT C-2 OF THE N-ACETYLGLUCOSAMINE RESIDUE: PROBES FOR INVESTIGATION OF ACCEPTOR SPECIFICITY OF HUMAN alpha-1,3-FUCOSYLTRANSFERASES, FUC-TVII AND FUC-TVI

机译:N-乙酰氨基葡萄糖残基的C-2修饰的唾液酸-α-(2-> 3)-新戊内酯衍生物的合成:用于研究人类α-1、3-葡糖基转移酶,FUC-TVII和FUC-T的受体特异性的问题

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A variety of siaryl-alpha-(2->3)-neolactotetraose (IV~3NeuAcnLc0se_4 or IV~3NeuGcnLc0se_4) derivatives (23, 31-37, 58-60) modified at C-2 of the GlcNAc residue have been synthesized. The phthalimido group at C-2 of GlcNAc in 2-(trimethylsilyl)ethyl (3,6-di-O-benzyl-2-deoxy-2-phthalimido-beta-D-glucopyranosyl)-(l->3)-(2,4,6-tri-O-benzyl-(3-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside (5) was systematically converted to a series of acylamino groups, to give the per-O-benzylated tri-saccharide acceptors (6-11). On the other hand, modification of the hydroxyl group at C-2 of the terminal Glc residue in 2-(trimethylsilyl)ethyl (4,6-0-benzylidene-P-D-glucopyranosyl)-(l->3)-(2,4,6-tri-O-benzyl-beta-D-galactopyr-anosyl)-(l->4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside (42) gave three different kinds of trisaccharide acceptors containing D-glucose (49), N-acetyl-D-mannosamine (50), and D-mannose (51) instead of the GlcNAc residue. Totally ten trisaccharide acceptors (5-11 and 49-51) were each coupled with sialyl-alpha-(2->3)-galactose donor 12 to afford the corresponding pentasacchar-ides (14-21 and 52-54) in good yields, respectively, which were then transformed into the target compounds. Acceptor specificity of the synthetic sialyl-alpha-(2->3)-neolactotetraose probes for the human alpha-(l->3)-fucosyltrans-ferases, Fuc-TVII and Fuc-TVI, was examined.
机译:已经合成了在GlcNAc残基的C-2处修饰的多种甲硅烷基-α-(2-> 3)-新四糖(IV〜3NeuAcnLc0se_4或IV〜3NeuGcnLc0se_4)衍生物(23、31-37、58-60)。 2-(三甲基甲硅烷基)乙基(3,6-二-O-苄基-2-脱氧-2-邻苯二甲酰亚胺-β-D-吡喃葡萄糖基)-(1-> 3)-( 2,4,6-三-O-苄基-(3-D-吡喃半乳糖基)-(1-> 4)-2,3,6-三-O-苄基-β-D-吡喃葡萄糖苷(5)被系统转化形成一系列酰基氨基,得到过-O-苄基化的三糖受体(6-11);另一方面,修饰2-(三甲基甲硅烷基)末端Glc残基的C-2处的羟基乙基(4,6-0-亚苄基-PD-吡喃葡萄糖基)-(1-> 3)-(2,4,6-三-O-苄基-β-D-吡喃半乳糖基-)(1-> 4) -2,3,6-三-O-苄基-β-D-吡喃葡萄糖苷(42)得到三种不同的三糖受体,分别包含D-葡萄糖(49),N-乙酰基-D-甘露糖胺(50)和D-甘露糖(51)而不是GlcNAc残基。总共十个三糖受体(5-11和49-51)分别与唾液酸-α-(2-> 3)-半乳糖供体12偶联,得到相应的五糖(14) -21和52-54)的高收益率,分别是n转化为目标化合物。检查了合成的唾液酸-α-(2-> 3)-神经四糖探针对人α-(1-> 3)-岩藻糖基转移酶Fuc-TVII和Fuc-TVI的受体特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号